Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
260M
-
Number of holders
-
935
-
Total 13F shares, excl. options
-
174M
-
Shares change
-
+174M
-
Total reported value, excl. options
-
$5.26B
-
Value change
-
+$5.25B
-
Put/Call ratio
-
1.3
-
Number of buys
-
925
-
Price
-
$30.26
Significant Holders of Organon & Co. - Common Stock (OGN) as of Q2 2021
952 filings reported holding OGN - Organon & Co. - Common Stock as of Q2 2021.
Organon & Co. - Common Stock (OGN) has 935 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 174M shares
of 260M outstanding shares and own 66.82% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (28.9M shares), BlackRock Inc. (16.5M shares), STATE STREET CORP (8.49M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (5.78M shares), GEODE CAPITAL MANAGEMENT, LLC (5.07M shares), WELLINGTON MANAGEMENT GROUP LLP (4.48M shares), Bank of New York Mellon Corp (4.24M shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (3.93M shares), JPMORGAN CHASE & CO (3.79M shares), and Invesco Ltd. (3.54M shares).
This table shows the top 935 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.